John Maertens
Impact in
- Hematology top 5%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
-
- Antifungal resistance and susceptibility
Papers in
-
- Acute Myeloid Leukemia Research 5
- Hematopoietic Stem Cell Transplantation 3
- Chronic Myeloid Leukemia Treatments 2
-
- Lymphoma Diagnosis and Treatment 4
- Co-authors
- Jan J. Cornelissen (4 shared papers)Anna Sureda (2 shared papers)Sébastian Wittnebel (1 shared paper)Roberto Foà (1 shared paper)Gustaaf Willem Van Imhoff (1 shared paper)Nicolas Mounier (1 shared paper)Michel Attal (1 shared paper)J.J. Luan (1 shared paper)
- Journals
- Bone Marrow Transplantation (3 papers)Blood (3 papers)International Journal of Gynecological Cancer (1 paper)Journal of Internal Medicine (1 paper)Transplantation and Cellular Therapy (1 paper)
- Partner nations
- BelgiumFranceNetherlands
In The Last Decade
John Maertens
14 papers receiving 469 citations
Peers
Comparison fields: 5 of 41
- Hematology 172
- Infectious Diseases 135
- Pathology and Forensic Medicine 114
- Genetics 69
- Oncology 151
Countries citing papers authored by John Maertens
This map shows the geographic impact of John Maertens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Maertens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Maertens more than expected).
Fields of papers citing papers by John Maertens
This network shows the impact of papers produced by John Maertens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Maertens. The network helps show where John Maertens may publish in the future.
Co-authors
The 25 scholars most cited alongside John Maertens, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 105 | |
| 2 | 2011 | 98 | |
| 3 | 2010 | 62 | |
| 4 | 2014 | 48 | |
| 5 | 2016 | 35 | |
| 6 | 2009 | 32 | |
| 7 | 2017 | 26 | |
| 8 | 2015 | 24 | |
| 9 | 2004 | 16 | |
| 10 | 2015 | 14 | |
| 11 | 2005 | 13 | |
| 12 | Treatment of primary amyloidosis with VAD combination chemotherapy results in improved survival | 1996 | 6 |
| 13 | Prognostic value of pretransplant positron emission tomography using fluorine-18 fluorodeoxyglucose in patients with aggressive lymphoma treated with high-dose chemotherapy and stem cell transplantation | 2003 | 4 |
| 14 | 2009 | 1 |
About John Maertens
John Maertens is a scholar working on Hematology, Pathology and Forensic Medicine, Oncology, Infectious Diseases and Genetics, having authored 14 papers that have together received 484 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (5 papers), Lymphoma Diagnosis and Treatment (4 papers), Fungal Infections and Studies (3 papers), Hematopoietic Stem Cell Transplantation (3 papers), Antifungal resistance and susceptibility (3 papers), Chronic Myeloid Leukemia Treatments (2 papers), Neutropenia and Cancer Infections (2 papers) and Viral-associated cancers and disorders (2 papers). The work is most often cited by research in Hematology (172 citations), Infectious Diseases (135 citations), Pathology and Forensic Medicine (114 citations), Genetics (69 citations) and Oncology (151 citations). John Maertens has collaborated with scholars based in Belgium, France and Netherlands. Frequent co-authors include Jan J. Cornelissen, Anna Sureda, Sébastian Wittnebel, Roberto Foà, Gustaaf Willem Van Imhoff, Nicolas Mounier, Michel Attal, J.J. Luan, Mats L. Brune and Carmen Canals. Their work appears in journals such as Bone Marrow Transplantation, Blood, International Journal of Gynecological Cancer, Journal of Internal Medicine and Transplantation and Cellular Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.